Headache

Lindus Health Partners with Amendola for PR Program to Promote Groundbreaking Model that Streamlines End-to-End Clinical Trials for Life Sciences

Retrieved on: 
Thursday, April 4, 2024

Amendola is implementing a comprehensive PR plan to demonstrate Lindus Health's industry-leading technology and services, accomplishments, customer wins, and industry partnerships.

Key Points: 
  • Amendola is implementing a comprehensive PR plan to demonstrate Lindus Health's industry-leading technology and services, accomplishments, customer wins, and industry partnerships.
  • "We are thrilled to work with Amendola to demonstrate to the market how Lindus Health's new model offers more rapid, high-quality clinical trials together with transparent pricing."
  • The company is passionate about using the highest-quality scientific methods available and homegrown cutting-edge technology, including AI, to conduct radically faster, more reliable clinical trials.
  • "Lindus Health is poised to transform how clinical trials are executed and we look forward to raising awareness across the industry."

NURTEC ODT® is Now Available in Canada for the Treatment of Acute Migraine

Retrieved on: 
Thursday, April 4, 2024

KIRKLAND, QC, April 4, 2024 /CNW/ - NURTEC ODT® (rimegepant) is now available in Canada for use in the acute treatment of migraine, with or without aura in adults older than 18 years of age.iii NURTEC is an orally disintegrating calcitonin gene-related peptide (CGRP) receptor antagonist tablet.

Key Points: 
  • KIRKLAND, QC, April 4, 2024 /CNW/ - NURTEC ODT® (rimegepant) is now available in Canada for use in the acute treatment of migraine, with or without aura in adults older than 18 years of age.iii NURTEC is an orally disintegrating calcitonin gene-related peptide (CGRP) receptor antagonist tablet.
  • "It is an exciting time for Canadians to now have another targeted, migraine specific therapy in their management toolbox."
  • People living with migraine are looking for timely and equitable access to new options to effectively manage this highly debilitating disease," said Wendy Gerhart from Migraine Canada.
  • "Pfizer Canada is proud to bring this new therapy to Canadians impacted by migraine," said Andréa Mueller, Primary Care Portfolio Lead, Pfizer Canada.

FDA Approves New Antibiotic for Three Different Uses

Retrieved on: 
Wednesday, April 3, 2024

"The FDA will continue our important work in this area as part of our efforts to protect the public health."

Key Points: 
  • "The FDA will continue our important work in this area as part of our efforts to protect the public health."
  • Zevtera's efficacy in treating SAB was evaluated in a randomized, controlled, double-blind, multinational, multicenter trial .
  • In the trial, researchers randomly assigned 390 subjects to receive Zevtera (192 subjects) or daptomycin plus optional aztreonam [the comparator] (198 subjects).
  • A total of 69.8% of subjects who received Zevtera achieved overall success compared to 68.7% of subjects who received the comparator.

China has committed to boosting foreign investors' confidence and a sense of belonging

Retrieved on: 
Wednesday, April 3, 2024

Like Cook said, "there's no supply chain in the world that's more critical to us than China."

Key Points: 
  • Like Cook said, "there's no supply chain in the world that's more critical to us than China."
  • More foreign entrepreneurs have been visiting China lately, showing high spirits about investing in the country.
  • A reason behind the tide is that China has stepped up efforts in opening its doors wider and attracting and utilizing foreign investment.
  • China has committed itself to enhancing the confidence and the sense of belonging of foreign investors in China.

Hamline University Research Validates Highly Cost-Effective Impairment Assessment Algorithm for Workers' Compensation Cases

Retrieved on: 
Wednesday, April 3, 2024

ST. PAUL, Minn., April 3, 2024 /PRNewswire-PRWeb/ -- Hamline University, in collaboration with impairment rating calculations company Rate-Fast, today announced groundbreaking research that revolutionizes the assessment of impairment in workers' compensation cases. The study validates a novel algorithm-based Functional Loss Rating (FLR) method, which offers a more objective, efficient, and cost-effective approach for calculating a whole-person impairment (WPI) score, upon which compensation for work-related injuries is based. The study demonstrates that the computational FLR method is consistently more accurate than the traditional, manual Four Corners Rating (FCR) system, the current industry standard for WPI measurement.

Key Points: 
  • ST. PAUL, Minn., April 3, 2024 /PRNewswire-PRWeb/ -- Hamline University, in collaboration with impairment rating calculations company Rate-Fast, today announced groundbreaking research that revolutionizes the assessment of impairment in workers' compensation cases.
  • The study validates a novel algorithm-based Functional Loss Rating (FLR) method, which offers a more objective, efficient, and cost-effective approach for calculating a whole-person impairment (WPI) score, upon which compensation for work-related injuries is based.
  • FLR is a mathematical impairment evaluation method that uses advanced data analytics to calculate an objective, accurate WPI rating.
  • The algorithm at the heart of FLR was built on more than a decade of research comprised of nearly 70,000 impairment case rating experiences.

HeadaTerm 2: The Most Affordable FDA Cleared Innovative OTC Anti-Migraine Device

Retrieved on: 
Tuesday, April 2, 2024

Using neuromodulation technology, HeadaTerm 2 releases targeted electrical impulses to increase pain tolerance of its users.

Key Points: 
  • Using neuromodulation technology, HeadaTerm 2 releases targeted electrical impulses to increase pain tolerance of its users.
  • HeadaTerm 2 is a testament of WAT Medical's continued commitment to providing safe, effective, and user-friendly innovative medical devices at the most competitive price.
  • It provided an affordable solution to a debilitating condition that affects nearly 40 million people in the U.S. HeadaTerm 2 is a rechargeable device that features adjustable intensity setting and will be the most affordable device of its kind.
  • HeadaTerm 2 will appear at the 66th Annual Scientific Meeting in June 2024 hosted by American Headache Society.

Spence Law Firm LLC: Family Alleges Gas Poisoning in Airbnb Vacation Home

Retrieved on: 
Monday, April 1, 2024

SAN FRANCISCO and SANTA FE, N.M., April 1, 2024 /PRNewswire/ -- A Montana family of four alleges in new lawsuits that they were poisoned by a boiler spewing carbon monoxide gas into an Airbnb vacation rental home in Santa Fe, N.M., The Spence Law Firm and co-counsel said today.

Key Points: 
  • SAN FRANCISCO and SANTA FE, N.M., April 1, 2024 /PRNewswire/ -- A Montana family of four alleges in new lawsuits that they were poisoned by a boiler spewing carbon monoxide gas into an Airbnb vacation rental home in Santa Fe, N.M., The Spence Law Firm and co-counsel said today.
  • Tyson E. Logan , of The Spence Law Firm, said, "This is an urgent issue.
  • The poisoning did permanent and irreversible damage to this family, especially the youngest child – it will affect them forever.
  • Contact: Erin Powers, Powers MediaWorks LLC, for The Spence Law Firm, LLC, 281.703.6000, [email protected] .

Local Veteran Brings First California Pools Location to Temecula

Retrieved on: 
Monday, April 1, 2024

TEMECULA, Calif., April 1, 2024 /PRNewswire/ -- California Pools, the industry leader in custom residential swimming pool construction, is breaking ground with a franchise deal to bring its services to the Temecula market. This is the 16th California Pools location in California, with this location set to debut by April 2024.

Key Points: 
  • TEMECULA, Calif., April 1, 2024 /PRNewswire/ -- California Pools , the industry leader in custom residential swimming pool construction, is breaking ground with a franchise deal to bring its services to the Temecula market.
  • This is the 16th California Pools location in California, with this location set to debut by April 2024.
  • By working directly with the customers and trusted local sub-contractors, California Pools streamlines what can be a difficult and costly headache into a dream-made-real.
  • "We're looking forward to adding Ron and Laron to the California Pools family as we expand our services into the Temecula market," said Steve Terry, President of California Pools.

Insurers Underserve Migraine Patients, Comprehensive Survey Report Reveals

Retrieved on: 
Monday, April 1, 2024

WASHINGTON, April 1, 2024 /PRNewswire/ -- A joint survey report from The Headache and Migraine Policy Forum and Migraine Meanderings , released today, reveals that millions of migraine patients' access to care is hindered by health plans' utilization management practices.

Key Points: 
  • WASHINGTON, April 1, 2024 /PRNewswire/ -- A joint survey report from The Headache and Migraine Policy Forum and Migraine Meanderings , released today, reveals that millions of migraine patients' access to care is hindered by health plans' utilization management practices.
  • Nearly 50% of migraine patients say it takes their insurer more than one week to approve a prescribed treatment.
  • 33% of migraine patients say that they have experienced non-medical switching where insurance companies switch out the medications prescribed by patients' doctors.
  • Denials and delays are harmful, the report says, because they can leave patients without the proper tools to manage their migraine.

WYBOTICS Release the WYBOT C1 Cordless Robotic Pool Cleaner

Retrieved on: 
Monday, April 1, 2024

LOS ANGELES, April 1, 2024 /PRNewswire/ -- WYBOTICS, an innovator in the swimming pool cleaning and maintenance device world, recently celebrated the news its latest breakthrough is available, the WYBOT C1 Cordless Robotic Pool Cleaner for In-Ground Pools. This new piece of swimming pool tech represents an advancement over previous models, skyrocketing efficient "hands-free" cleaning for homeowners.

Key Points: 
  • LOS ANGELES, April 1, 2024 /PRNewswire/ -- WYBOTICS, an innovator in the swimming pool cleaning and maintenance device world, recently celebrated the news its latest breakthrough is available, the WYBOT C1 Cordless Robotic Pool Cleaner for In-Ground Pools .
  • The WYBOT C1 Cordless Robotic Pool Cleaner is designed to address the evolving needs of in-ground pool owners, offering a host of advanced features and enhancements over previous models.
  • Furthermore, the 2024 WYBOT C1 Cordless Robotic Pool Cleaner offers the convenience of scheduled cleaning through a dedicated app.
  • In conclusion, the launch of the 2024 WYBOT C1 Cordless Robotic Pool Cleaner represents a significant milestone in pool maintenance technology.